Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jogender Tushir-Singh

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Expert Opinion on Biological Therapy|December 16, 2016
Antibody-siRNA conjugates: drugging the undruggable for anti-leukemic therapyJogender Tushir-Singh
Methods in Molecular Biology (Clifton, N.J.)|November 11, 2016
In Vitro Assay to Study Histone Ubiquitination During Transcriptional RegulationJogender Tushir-Singh, Sanchita Bhatnagar
Molecular & Cellular Oncology|May 28, 2019
Targeting HER2 beyond breast cancerSanchita Bhatnagar, Jogender Tushir-Singh
Cancer Cell|May 11, 2021
Arming "old guards" with "new dual-targeting weapons"Lawrence G Lum, Jogender Tushir-Singh
Microbiology Spectrum|February 9, 2022
A Feasible Alternative Strategy Targeting Furin Disrupts SARS-CoV-2 Infection CycleTanmoy Mondal, Gururaj Shivange, Alaa Habieb, et al.
Expert Opinion on Biological Therapy|April 26, 2021
Bispecific antibodies for the treatment of breast cancerPatrick M Dillon, Jogender Tushir-Singh, Lawrence G Lum
Journal of Visualized Experiments : Jove|June 2, 2020
Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic AntibodyGururaj Shivange, Tanmoy Mondal, Evan Lyerly, et al.
The Journal of Biological Chemistry|November 22, 2025
An evolutionary T119R substitution in the macaque T-cell immunoreceptor TIGIT enables proteolytic shedding and reveals clinical antibody vulnerabilitiesEric Pirillo, Francis Freenor V, Brice E N Wamba, et al.
Cell Reports|November 3, 2021
A patch of positively charged residues regulates the efficacy of clinical DR5 antibodies in solid tumorsGururaj Shivange, Tanmoy Mondal, Evan Lyerly, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 18, 2018
Pharmacological reactivation of inactive X-linked <i>Mecp2</i> in cerebral cortical neurons of living micePiotr Przanowski, Urszula Wasko, Zeming Zheng, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Expert Opinion on Biological Therapy|December 16, 2016
Antibody-siRNA conjugates: drugging the undruggable for anti-leukemic therapyJogender Tushir-Singh
Methods in Molecular Biology (Clifton, N.J.)|November 11, 2016
In Vitro Assay to Study Histone Ubiquitination During Transcriptional RegulationJogender Tushir-Singh, Sanchita Bhatnagar
Molecular & Cellular Oncology|May 28, 2019
Targeting HER2 beyond breast cancerSanchita Bhatnagar, Jogender Tushir-Singh
Cancer Cell|May 11, 2021
Arming "old guards" with "new dual-targeting weapons"Lawrence G Lum, Jogender Tushir-Singh
Microbiology Spectrum|February 9, 2022
A Feasible Alternative Strategy Targeting Furin Disrupts SARS-CoV-2 Infection CycleTanmoy Mondal, Gururaj Shivange, Alaa Habieb, et al.
Expert Opinion on Biological Therapy|April 26, 2021
Bispecific antibodies for the treatment of breast cancerPatrick M Dillon, Jogender Tushir-Singh, Lawrence G Lum
Journal of Visualized Experiments : Jove|June 2, 2020
Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic AntibodyGururaj Shivange, Tanmoy Mondal, Evan Lyerly, et al.
The Journal of Biological Chemistry|November 22, 2025
An evolutionary T119R substitution in the macaque T-cell immunoreceptor TIGIT enables proteolytic shedding and reveals clinical antibody vulnerabilitiesEric Pirillo, Francis Freenor V, Brice E N Wamba, et al.
Cell Reports|November 3, 2021
A patch of positively charged residues regulates the efficacy of clinical DR5 antibodies in solid tumorsGururaj Shivange, Tanmoy Mondal, Evan Lyerly, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 18, 2018
Pharmacological reactivation of inactive X-linked <i>Mecp2</i> in cerebral cortical neurons of living micePiotr Przanowski, Urszula Wasko, Zeming Zheng, et al.
Pageof 2